<img alt="" src="https://secure.soil5hear.com/223550.png" style="display:none;">
Skip to content

SSTR2 Radiopharmaceutical In Vivo Screen

Advance your SSTR2-targeted radiopharmaceutical programs with 38 clinically relevant patient-derived models, including neuroendocrine subtypes.

Enrollment now open

 

 

Request more information on our SSTR2 Radiopharmaceutical Screen

Accelerate Your SSTR2 Drug Discovery with Clinically Relevant Models

The SSTR2 Radiopharmaceutical Screen features a curated panel of 38 patient-derived models, including neuroendocrine tumors, Merkel cell carcinoma, and select small cell lung cancer (SCLC) models with confirmed SSTR2 expression. These models reflect patient tumor biology and capture heterogeneity across tumor types, enabling translationally meaningful insights for therapeutic and theranostic development.

38 Clinically Relevant Models

A curated panel of patient-derived xenograft  models with SSTR2 expression, including rare neuroendocrine models

Integrated Radiochemistry & Radiopharmacology

The only CRO with both capabilities in-house, offering seamless workflows from radiolabeling througho in vivo readouts

Focused Readout

Tumor Growth Inhibition (TGI) provided as the primary endpoint for clear, actionable insights

Champions Oncology’s radiopharmacology screens reduce uncertainty with translationally relevant PDX models, enabling earlier go/no-go decisions and supporting both therapeutic and theranostic programs. As the only CRO with integrated radiochemistry and radiopharmacology in-house, we provide a seamless path from radiolabeling to in vivo insights.

  • Enrollment now open, limited availability
  • Comprehensive metadata and tumor annotations included
  • Flexible endpoints available to support biodistribution and efficacy analyses
  • No SOC arm required, rapid study initiation possible
  • Lutathera (177Lu-Dotatate) will be offered as the shared SoC arm at 50% discount.

Champions Oncology’s radiopharmacology screens reduce uncertainty with translationally relevant PDX models, enabling earlier go/no-go decisions and supporting both therapeutic and theranostic programs. As the only CRO with integrated radiochemistry and radiopharmacology in-house, we provide a seamless path from radiolabeling to in vivo insights.

  • Enrollment now open, limited availability
  • Comprehensive metadata and tumor annotations included
  • Flexible endpoints available to support biodistribution and efficacy analyses
  • No SOC arm required, rapid study initiation possible
  • Lutathera (177Lu-Dotatate) will be offered as the shared SoC arm at 50% discount.
SSTR2 Radiopharmaceutical Screen Models

Our screen includes 38 models across head and neck, neuroendocrine, and other clinically relevant tumor types. Each model is annotated with SSTR2 expression data and optimized for radiopharmaceutical evaluation.

Model
Tumor type
Histology
CTG-0258
Ovarian
histology
CTG-1138
Ovarian
N/A
CTG-2178
Bladder
histology
CTG-0199
SCLC
histology
CTG-3991
Endometrial
histology
CTG-1561
Uterine
histology
CTG-1260
Breast
histology
CTG-3346
Breast
histology
CTG-3500
Breast
histology
CTG-0462
Head and neck
histology
CTG-3581
Prostate
histology
CTG-0232
Merkel cell
histology
CTG-0198
SCLC
histology
CTG-1814
NSCLC
histology
CTG-2930
Breast
histology
CTG-1280
Endometrial
histology
CTG-2441
Prostate
histology
CTG-3533
Breast
histology
CTG-1423
Ovarian
histology
CTG-2647
Endometrial
histology
CTG-3399
Breast
histology
CTG-3347
Breast
histology
CTG-1703
Ovarian
histology
CTG-0282
Pancreatic
histology
CTG-0473
Breast
histology
CTG-0901
Head and neck
histology
CTG-1714
Breast
histology
CTG-1921
Thyroid
histology
CTG-2812
Cervical
histology
CTG-3140
Cervical
histology
CTG-1218
SCLC
histology
CTG-4320
Neuroendocrine
histology
CTG-3779
Neuroendocrine tumor
histology
CTG-0079
Colorectal
histology
CTG-0231
Merkel cell
histology
CTG-4282
Prostate
N/A
CTG-4282
Prostate
N/A
CTG-4404
SCLC
N/A

Get Started Today

Contact our team to secure your place in the SSTR2 Radiopharmaceutical Screen and accelerate your targeted drug discovery.